Anthropic Confidentially Files S-1 at $965B Valuation
Anthropic has filed a confidential S-1 registration statement with the SEC, pegging its valuation at $965 billion — marginally ahead of OpenAI's $852 billion — as 2026 solidifies into the year frontier AI labs go public. Revenue run-rate reached $47 billion, up roughly 5× from $9 billion at end-2025, fueled by enterprise adoption of Claude for coding and workflow automation. Six independent intelligence batches — email newsletters, YouTube, and four X/Twitter waves — all confirmed the filing within the same 24-hour window, making it the most cross-corroborated story in today's pool.
What the Source Actually Says
AlphaSignal's June 3 newsletter broke down the mechanics: a confidential S-1 lets the SEC review privately before public disclosure; no share count or offering price has been set. The filing preserves optionality — Anthropic can pursue or delay an IPO without the immediate disclosure obligations of a live public filing. A parallel Substack note identified a $65 billion Series H led by Altimeter, Dragoneer, Greenoaks, and Sequoia running concurrently, confirming that private appetite for Anthropic paper remains strong even as the public-market path opens.
Multiple X/Twitter accounts expanded the picture independently. @techsnif surfaced a New York Times report confirming the filing, and separately noted that Salesforce now holds a roughly $5 billion stake — its $50 million 2023 seed position compounded through subsequent rounds. Gary Marcus framed the cohort plainly: Anthropic, OpenAI, and SpaceX have collectively "exhausted private market appetite" and are being pushed into public markets, positioning the IPO wave as an insider-exit event rather than a capital-need event. IBM CEO Arvind Krishna's counter-narrative landed the same day — $6–8 trillion in AI capex chases revenue that, by his estimate, "doesn't exist" — a sobering counterweight amplified across the same batches.
YouTube coverage from Lev Selector and The Next New Thing placed the valuation in the $900B–$1T range, consistent with AlphaSignal's specific $965B figure.
Strategic Take
Claude and Claude Code are now on a public-market glide path. Quarterly scrutiny will reshape vendor pricing, rate limits, and model availability in ways a private lab can defer indefinitely. For teams that have built on subsidized frontier access, the practical question is when — not if — commercial terms normalize toward sustainable margin. The $47B run-rate is the IPO's hero number; how much of it survives CFO-level scrutiny post-listing determines the next two years of the model-provider relationship.
